OAM
CKPT

Occidental Asset Management’s Checkpoint Therapeutics CKPT Stock Holding History

Occidental Asset Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,640
Closed -$27K – 207
2022
Q3 		$27K Hold
2,640
– – 0.01% 180
2022
Q2 		$27K Hold
2,640
– – 0.01% 179
2022
Q1 		$47K Hold
2,640
– – 0.01% 189
2021
Q4 		$82K Hold
2,640
– – 0.02% 206
2021
Q3 		$87K Hold
2,640
– – 0.02% 205
2021
Q2 		$78K Hold
2,640
– – 0.02% 200
2021
Q1 		$83K Buy
+2,640
New +$88.5K 0.02% 187

Other funds holding CKPT

TC
TwinBeech Capital Purchase, New York $965M AUM 0.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Occidental Asset Management's CKPT Position: Q4 2022 in Review

Occidental Asset Management sold out of Checkpoint Therapeutics (CKPT) in Q4 2022, closing a stake of 2,640 shares — an estimated $27K sold.

Occidental Asset Management first reported a position in CKPT in Q1 2021 and held it in 7 quarters. The position peaked at $87K in Q3 2021. 40 funds tracked by Wall St. Rank hold CKPT as of Q4 2022.

  • Occidental Asset Management reported no remaining Checkpoint Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Occidental Asset Management sold 2,640 Checkpoint Therapeutics shares in Q4 2022, an estimated $27K.
  • Occidental Asset Management first reported a position in Checkpoint Therapeutics in Q1 2021 and held it in 7 quarters.
  • Occidental Asset Management's Checkpoint Therapeutics position peaked at $87K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2022.

Based on Occidental Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.